why choose us

First received: November 15, 2023

Clinical Trial: Study to Assess the Biochemical Similarity of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Heathy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-blind, Single-dose, Partial Replicate, 3-period Cross-over Study to Assess the Total Systemic Exposure Bioequivalence of Budesonide and Albuterol Delivered by BDA MDI Hyd

Brief Summary: This study will investigate the Pharmacokinetic (PK) and safety of Budesonide and albuterol (BDA) metered dose inhaler (MDI) HFO and BDA MDI HFA in healthy male and female participants.

Read more